39 research outputs found
Role of the endogenous cannabinoid system as a modulator of dopamine transmission: Implications for Parkinson’s disease and schizophrenia
Full text linkPreclinical and early clinical investigations related to monoaminergic pain modulation
Full text linkThe cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease.
Full text linkActivation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.
Full text linkOn the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus
Full text linkFunctional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.
Full text linkModulation of GABA transmission by diazoxide and cromakalim in the globus pallidus: implications for the treatment of Parkinson's disease.
Full text linkAntiparkinsonian action of a δ opioid agonist in rodent and primate models of Parkinson's disease
Full text link
